Literature DB >> 31660317

CardioMEMS: where we are and where can we go?

Issa Pour-Ghaz1, David Hana2, Joel Raja1, Uzoma N Ibebuogu3, Rami N Khouzam3.   

Abstract

The prevalence of heart failure (HF) has been on the rise with associated increase in hospitalizations, morbidity and mortality. These hospitalizations have led to increasingly more cost on and decreased quality of life for patients. CardioMEMS is one of the newer devices designed to help tackle this issue by allowing for better monitoring of HF patients. This device also allows for accurate recording of pulmonary artery pressures (PAPs) and has also been applied in various other areas, such as aneurysmal tears, for monitoring pressures. In this manuscript we will review the current state of CardioMEMS HF system and investigate some of the other areas for its promising use in the field. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  CardioMEMS; congestive heart failure (CHF); heart failure preserved ejection fraction (HFpEF); heart failure reduced ejection fraction (HFrEF); pulmonary artery hypertension (PAH)

Year:  2019        PMID: 31660317      PMCID: PMC6787393          DOI: 10.21037/atm.2019.07.53

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  39 in total

Review 1.  Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature.

Authors:  John Robert Swiston; Sindhu R Johnson; John T Granton
Journal:  Respir Med       Date:  2010-11       Impact factor: 3.415

Review 2.  Epidemiology and risk profile of heart failure.

Authors:  Anh L Bui; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2010-11-09       Impact factor: 32.419

3.  Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure.

Authors:  W H Wilson Tang; John P Girod; Michael J Lee; Randall C Starling; James B Young; Frederick Van Lente; Gary S Francis
Journal:  Circulation       Date:  2003-12-08       Impact factor: 29.690

4.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

5.  Safety and feasibility of pulmonary artery pressure-guided heart failure therapy: rationale and design of the prospective CardioMEMS Monitoring Study for Heart Failure (MEMS-HF).

Authors:  Christiane E Angermann; Birgit Assmus; Stefan D Anker; Johannes Brachmann; Georg Ertl; Friedrich Köhler; Stephan Rosenkranz; Carsten Tschöpe; Philip B Adamson; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-19       Impact factor: 5.460

Review 6.  Remote heart function monitoring: role of the CardioMEMS HF System.

Authors:  Emilio Vanoli; Emilia D'Elia; Maria T La Rovere; Edoardo Gronda
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2016-07       Impact factor: 2.160

7.  Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.

Authors:  Philip B Adamson; William T Abraham; Robert C Bourge; Maria Rosa Costanzo; Ayesha Hasan; Chethan Yadav; John Henderson; Pam Cowart; Lynne Warner Stevenson
Journal:  Circ Heart Fail       Date:  2014-10-06       Impact factor: 8.790

8.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

Review 9.  Ambulatory Heart Failure Monitoring: A Systemic Review.

Authors:  Muhammad A Mangi; Hiba Rehman; Muhammad Rafique; Michael Illovsky
Journal:  Cureus       Date:  2017-04-18

Review 10.  Hemoptysis After CardioMEMS Implantation: Case Report and Review.

Authors:  Aniket S Rali; Zubair Shah; Andrew J Sauer; Kamal Gupta
Journal:  Am J Case Rep       Date:  2018-03-31
View more
  5 in total

1.  It is easy to see, but it is better to foresee: a case report on the favourable alliance between CardioMEMS and levosimendan.

Authors:  Valeria Visco; Cristina Esposito; Paolo Vitillo; Carmine Vecchione; Michele Ciccarelli
Journal:  Eur Heart J Case Rep       Date:  2020-06-30

2.  Portable ultrasound assessment of jugular venous pressure is an accurate method for estimating volaemic status in patients with cardiac disease.

Authors:  Sam Jenkins; Patrick Knowles; Norman Briffa
Journal:  J Ultrasound       Date:  2022-03-15

Review 3.  Medical management of acute heart failure.

Authors:  Hayaan Kamran; W H Wilson Tang
Journal:  Fac Rev       Date:  2021-12-06

Review 4.  Big Data Approaches in Heart Failure Research.

Authors:  Jan D Lanzer; Florian Leuschner; Rafael Kramann; Rebecca T Levinson; Julio Saez-Rodriguez
Journal:  Curr Heart Fail Rep       Date:  2020-10

Review 5.  Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era.

Authors:  Aneta Aleksova; Gianfranco Sinagra; Antonio P Beltrami; Alessandro Pierri; Federico Ferro; Milijana Janjusevic; Giulia Gagno
Journal:  ESC Heart Fail       Date:  2021-10-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.